Wednesday, April 17, 2019

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead - STAT

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead  STAT

It is the company's first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.



No comments:

Post a Comment